Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;478(3):605-610.
doi: 10.1007/s00428-020-02864-y. Epub 2020 Jun 12.

Primary hepatic carcinoma with inhibin positivity in a young male patient: a rare tumor previously only reported in females-case report and review of literature

Tom Z Liang  1 , Gilbert Whang  2 , Shefali Chopra  3
Affiliations
Review

Primary hepatic carcinoma with inhibin positivity in a young male patient: a rare tumor previously only reported in females-case report and review of literature

Tom Z Liang et al. Virchows Arch. 2021 Mar.

Abstract

Primary hepatic carcinoma with inhibin positivity is a rare aggressive liver tumor with seven cases described. The tumor presents at a younger age than primary hepatic carcinoma with all cases being females. RNA albumin ISH positivity suggests the tumor to be a primary hepatic carcinoma. The tumor is different from hepatocellular carcinoma as well as intrahepatic cholangiocarcinoma because of its distinct morphology, lack of hepatocellular differentiation, strong inhibin staining, and lack of typical mutations. A 26-year-old male presented with a 20-cm liver mass. The tumor progressed on therapy with development of multiple lung metastasis. Currently, the patient is enrolled in phase II clinical trial utilizing nivolumab and ipilumumab. While the tumor has a female preponderance, it is not exclusively found in females. Additional studies are necessary to determine the cause of inhibin staining, driving molecular alterations, natural history of this rare tumor, and to come up with consensus nomenclature.

Keywords: Inhibin positive; Primary hepatic carcinoma; RNA albumin ISH positive.

PubMed Disclaimer

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424 - PubMed - PMC
    1. Vrettou E, Hytiroglou P, Sikas N, Soultoyannis I, Goodman ZD (2005) Hepatic adenocarcinoma expressing inhibin in a young patient on oral contraceptives. Virchows Arch 446:560–565. https://doi.org/10.1007/s00428-005-1241-3 - DOI - PubMed
    1. Braxton DR, Saxe D, Damjanov N, Stashek K, Shroff S, Morrissette JD, Tondon R, Furth EE (2017) Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as “cholangioblastic variant of intrahepatic cholangiocarcinoma”. Hum Pathol 62:232–241. https://doi.org/10.1016/j.humpath.2017.02.001 - DOI - PubMed
    1. Wen KW, Srivastava A, Joseph N, Saunders T, Kakar S (2019) “Sex Cord-Like” hepatic carcinoma: a rare variant of intrahepatic cholangiocarcinoma? Abstract 1537. Page 54. Laboratory Investigation. Volume 99, Supplement 1
    1. Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W, McPherson JR, Allen GE, Ng CCY, Wong BH, Myint SS, Rajasegaran V, Heng HL, Gan A, Zang ZJ, Wu Y, Wu J, Lee MH, Huang DC, Ong P, Chan-on W, Cao Y, Qian CN, Lim KH, Ooi A, Dykema K, Furge K, Kukongviriyapan V, Sripa B, Wongkham C, Yongvanit P, Futreal PA, Bhudhisawasdi V, Rozen S, Tan P, Teh BT (2012) Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet 44:690–693 - DOI

MeSH terms

LinkOut - more resources